Journal article · 2026 · Open access
Mechanistic Population Pharmacokinetic Modeling of Extended‐Release Metformin in Obese South African Women Living with HIV on Dolutegravir
Clinical Pharmacology & Therapeutics · Published 7 November 2026 · DOI 10.1002/cpt.70565
In brief
“Mechanistic Population Pharmacokinetic Modeling of Extended‐Release Metformin in Obese South African Women Living with HIV on Dolutegravir” is a 2026 journal article by Rohan M. Benecke and 3 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 0 citations as of 16 November 2026. It is open access under a CC BY-NC licence: the full text is free to read at Clinical Pharmacology & Therapeutics.
- Citations
- 0
- References
- 23
- Authors
- 4
Abstract
Regulatory limits on metformin co‐administered with dolutegravir (DTG) derive from healthy‐volunteer studies in which DTG increased metformin exposure by 79% through organic cation transporter 2 inhibition, prompting a 1,000 mg/day metformin dose restriction. Whether this applies to women with HIV and severe obesity, a clinically important and understudied population for metformin‐DTG coadministration, is unknown. In a secondary analysis of a reported cohort, we developed a population pharmacokinetic model of extended‐release (XR) metformin with a zero‐order‐release, first‐order‐absorption structure scaled by lean body mass (LBM). Estimated glomerular filtration rate and DTG exposure were evaluated as clearance covariates, including DTG as a time‐varying competitive inhibitor. We simulated steady‐state exposures across body mass index (BMI) 30–60 kg/m 2 at 1000–3000 mg once daily compared to a DTG‐free reference model. Fifteen women contributed evaluable profiles (mean BMI 45.6 kg/m 2 ). Apparent clearance was 70.2 L/h, approximately 40% higher than reported non‐obese values, and DTG exposure was approximately 54% lower than in volunteer studies. LBM dominated clearance and volume, while no DTG exposure‐dependent effect on metformin clearance was identifiable within the observed low DTG exposure range. Simulated exposures rose near‐proportionally with dose and minimally with BMI; the proportion exceeding the lactic acidosis‐associated maximum concentration of 5 mg/L was 4.4% at 2000 mg/day, 16.9% at 2500 mg/day and 37.9% at 3000 mg/day, whereas none exceeded the lactic acidosis‐associated average steady‐state concentration of 4 mg/L. Although an interaction at higher DTG exposures cannot be excluded, the low exposures observed suggest the 1,000 mg/day restriction may underdose this obese population, supporting investigation of doses up to 2000 mg/day as the maximum authorized daily dose for metformin XR.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Benecke, R. M., Lorente, V. P.-F., Decloedt, E. H., & van Rensburg, R. (2026). Mechanistic Population Pharmacokinetic Modeling of Extended‐Release Metformin in Obese South African Women Living with HIV on Dolutegravir. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70565
MLA 9
Benecke, Rohan M., et al. “Mechanistic Population Pharmacokinetic Modeling of Extended‐Release Metformin in Obese South African Women Living with HIV on Dolutegravir.” Clinical Pharmacology & Therapeutics, 2026. https://doi.org/10.1002/cpt.70565.
Chicago
Benecke, Rohan M., Veshni Pillay-Fuentes Lorente, Eric H. Decloedt, and Roland van Rensburg. 2026. “Mechanistic Population Pharmacokinetic Modeling of Extended‐Release Metformin in Obese South African Women Living with HIV on Dolutegravir.” Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70565.
Harvard
Benecke, R. M. et al. (2026) ‘Mechanistic Population Pharmacokinetic Modeling of Extended‐Release Metformin in Obese South African Women Living with HIV on Dolutegravir’, Clinical Pharmacology & Therapeutics. doi:10.1002/cpt.70565.
IEEE
R. M. Benecke, V. P.-F. Lorente, E. H. Decloedt, and R. van Rensburg, “Mechanistic Population Pharmacokinetic Modeling of Extended‐Release Metformin in Obese South African Women Living with HIV on Dolutegravir,” Clinical Pharmacology & Therapeutics, 2026, doi: 10.1002/cpt.70565.
BibTeX
@article{benecke2026mechanistic,
title = {{Mechanistic Population Pharmacokinetic Modeling of Extended‐Release Metformin in Obese South African Women Living with HIV on Dolutegravir}},
author = {Benecke, Rohan M. and Lorente, Veshni Pillay-Fuentes and Decloedt, Eric H. and van Rensburg, Roland},
journal = {Clinical Pharmacology \& Therapeutics},
year = {2026},
doi = {10.1002/cpt.70565},
url = {https://doi.org/10.1002/cpt.70565}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- extended-release metformin
- dolutegravir
- drug-drug interactions
- obesity
- HIV
- women
- population pharmacokinetic model
- lean body mass
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Benecke, R. M., Lorente, V. P.-F., Decloedt, E. H., & van Rensburg, R. (2026). Mechanistic Population Pharmacokinetic Modeling of Extended‐Release Metformin in Obese South African Women Living with HIV on Dolutegravir. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.70565
How many times has this paper been cited?
0 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.
Who wrote this paper?
Rohan M. Benecke, Veshni Pillay-Fuentes Lorente, Eric H. Decloedt, Roland van Rensburg.
What is the DOI of this paper?
10.1002/cpt.70565, permanently at https://doi.org/10.1002/cpt.70565. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.